Table 7.
Top 20 co-occurrence keywords involved in the research of RCC immunotherapy.
| Rank | Keywords | Occurrences | TLS | Rank | Keywords | Occurrences | TLS |
|---|---|---|---|---|---|---|---|
| 1 | renal cell carcinoma | 1286 | 5641 | 11 | tyrosine kinase inhibitors | 123 | 715 |
| 2 | immunotherapy | 1200 | 5625 | 12 | biomarkers | 122 | 573 |
| 3 | cancer | 207 | 1021 | 13 | prognosis | 119 | 517 |
| 4 | interleukin-2 | 178 | 786 | 14 | melanoma | 116 | 617 |
| 5 | immune checkpoint inhibitors | 175 | 916 | 15 | checkpoint inhibitors | 104 | 605 |
| 6 | targeted therapy | 173 | 811 | 16 | dendritic cells | 98 | 592 |
| 7 | nivolumab | 154 | 851 | 17 | clear cell renal cell carcinoma | 98 | 536 |
| 8 | pd-1 | 147 | 878 | 18 | sunitinib | 83 | 433 |
| 9 | metastatic renal cell carcinoma | 146 | 663 | 19 | tumor microenvironment | 82 | 425 |
| 10 | pd-l1 | 128 | 793 | 20 | metastasis | 74 | 320 |
TLS, Total Link Strength.